USA - NASDAQ:SKIN - US88331L1089 - Common Stock
Taking everything into account, SKIN scores 2 out of 10 in our fundamental rating. SKIN was compared to 36 industry peers in the Personal Care Products industry. SKIN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SKIN is valued expensive and it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.74% | ||
ROE | -25.68% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 63.21% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.91 | ||
Debt/FCF | 10.75 | ||
Altman-Z | -0.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.15 | ||
Quick Ratio | 4.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 6.31 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:SKIN (10/8/2025, 2:35:09 PM)
1.68
+0.03 (+1.82%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.69 | ||
P/FCF | 6.31 | ||
P/OCF | 5.4 | ||
P/B | 2.88 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -3.74% | ||
ROE | -25.68% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 63.21% | ||
FCFM | 10.89% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.91 | ||
Debt/FCF | 10.75 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 24.4% | ||
Cap/Sales | 1.82% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 5.15 | ||
Quick Ratio | 4.15 | ||
Altman-Z | -0.14 |